Genetic products differentially expressed in tumors and use thereof | Patent Number 09453260

US 09453260 B2
Application Number14268160
Publication NumberUS 20150031025 A1
Pendency2 years, 4 months, 29 days
Filled DateMay 2, 2014
Priority DateMar 12, 2003
Publication DateJan 29, 2015
Expiration DateMar 12, 2023
Inventor/ApplicantsÖzlem Türeci
Ugur Sahin
Michael Koslowski
ExaminesHALVORSON, MARK
Art Unit1642
Technology Center1600
Assignments
Biontech Ag
Current
Ganymed Pharmaceuticals AgAstellas Pharma Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.